Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar - a podcast by Research To Practice

Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.
CME information and select publications here (https://www.researchtopractice.com/OncologyTodayBispecificNHL23)

Further episodes of Oncology Today with Dr Neil Love

Further podcasts by Research To Practice

Website of Research To Practice